This study describes a scenario in which the potentiation of CD4+ and CD8+ T cell activation and increased production of Th1 cytokines are associated with the clinical cure of tuberculosis in the absence of significant changes in the production of Th2 cytokines. The gene discussed is NELFCD; the disease is tuberculosis.